A randomised controlled trial of a low vision self-management program
A randomised controlled trial of a low vision self-management program on quality of life in people with low vision.
Associate Professor Jill Keeffe
240 participants
Mar 1, 2007
Interventional
Conditions
Summary
Study objectives • To determine the effectiveness of the ‘Living with Low Vision’ program in improving vision-specific quality of life and emotional well-being at 4, 10 and 16 months following baseline assessment in comparison with a control group with access to usual rehabilitation services. • To explore the impact of the ‘Living with Low Vision’ program on the uptake of rehabilitation services, use of low vision aids and devices, and home modification strategies. • To explore factors are associated with beneficial outcomes.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants are randomised to receive either the new low vision self-management program “Living with Low Vision” or continued access to usual low vision rehabilitation services. The “Living with Low Vision” program has been developed specifically for this study. It consists of eight 3-hour weekly facilitated group sessions. The program is structured and a facilitator manual clearly outlines the content and delivery. As well as providing information, the topics in the program are covered by exploring participants’ experiences, difficulties and solutions. Participants are encouraged to draw on their extensive life experience and coping mechanisms and to develop new skills and strategies and apply these new techniques in their daily life. Participants are given the option to bring a relative, friend or carer to the program with them.
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000399493